In the orthotopic HCC Hepa1.6 model, mice treated with pAb HCC or anti–PD-L1 mAb displayed a marked improvement of their clinical condition and a prolonged survival in combined therapy. The gene discussed is CD274; the disease is hepatocellular carcinoma.